Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
D414241-5mg
|
5mg |
2
|
$59.90
|
|
|
D414241-25mg
|
25mg |
2
|
$195.90
|
|
|
D414241-50mg
|
50mg |
1
|
$332.90
|
|
|
D414241-100mg
|
100mg |
1
|
$528.90
|
|
Dehydrogenase Inhibitors
| Synonyms | C29H29Cl3FN3O4 | 2-Methylpropan-2-amine (E)-3-(1-(5-(2-fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)isoxazole-4-carbonyl)-3-methyl-1H-indol-4-yl)acrylate | DS-1001b | HY-129545 | AKOS040759242 | (E)-3-[1-[5-(2-fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)-1 |
|---|---|
| Specifications & Purity | ≥98% |
| Biochemical and Physiological Mechanisms | DS-1001b is an oral selective inhibitor of mutant IDH1 R132X with potential antineoplastic activity and is designed to penetrate the blood-brain barrier. |
| Storage Temp | Store at -20°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Action Type | INHIBITOR |
| Mechanism of action | Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor |
| Product Description |
Information DS-1001b (DS 1001) DS-1001b is an oral selective inhibitor of mutant IDH1 R132X with potential antineoplastic activity and is designed to penetrate the blood-brain barrier. Targets IDH1 R132X In vitro DS-1001b impairs the proliferation of IDH1 mutant chondrosarcoma cell lines and decreases 2-HG levels. In vivo Continuous administration of DS-1001b impairs tumor growth in xenograft mice. Cell Research(from reference) Cell lines:JJ012,L835 cell lines Concentrations:0-10µM Incubation Time:72 h |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Indoles and derivatives |
| Subclass | Indolecarboxylic acids and derivatives |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Indolecarboxylic acids and derivatives |
| Alternative Parents | 3-methylindoles Heterocyclic fatty acids Halogenated fatty acids Chlorobenzenes Branched fatty acids Unsaturated fatty acids Substituted pyrroles Isoxazoles Heteroaromatic compounds Oxacyclic compounds Monocarboxylic acids and derivatives Carboxylic acids Azacyclic compounds Organopnictogen compounds Organooxygen compounds Organofluorides Organochlorides Organic oxides Monoalkylamines Hydrocarbon derivatives Alkyl fluorides |
| Molecular Framework | Not available |
| Substituents | Indolecarboxylic acid derivative - 3-methylindole - Heterocyclic fatty acid - Halogenated fatty acid - Halobenzene - Chlorobenzene - Branched fatty acid - Fatty acyl - Fatty acid - Benzenoid - Unsaturated fatty acid - Substituted pyrrole - Monocyclic benzene moiety - Heteroaromatic compound - Isoxazole - Azole - Oxacycle - Azacycle - Monocarboxylic acid or derivatives - Carboxylic acid - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Primary amine - Organooxygen compound - Organonitrogen compound - Organofluoride - Organochloride - Organohalogen compound - Primary aliphatic amine - Amine - Alkyl halide - Alkyl fluoride - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as indolecarboxylic acids and derivatives. These are compounds containing a carboxylic acid group (or a derivative thereof) linked to an indole. |
| External Descriptors | Not available |
|
|
|
| IUPAC Name | (E)-3-[1-[5-(2-fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)-1,2-oxazole-4-carbonyl]-3-methylindol-4-yl]prop-2-enoic acid;2-methylpropan-2-amine |
|---|---|
| INCHI | InChI=1S/C25H18Cl3FN2O4.C4H11N/c1-12-11-31(17-6-4-5-13(19(12)17)7-8-18(32)33)24(34)21-22(30-35-23(21)25(2,3)29)20-15(27)9-14(26)10-16(20)28;1-4(2,3)5/h4-11H,1-3H3,(H,32,33);5H2,1-3H3/b8-7+; |
| InChIKey | UPPAAWQBZQBNIE-USRGLUTNSA-N |
| Smiles | CC1=CN(C2=CC=CC(=C12)C=CC(=O)O)C(=O)C3=C(ON=C3C4=C(C=C(C=C4Cl)Cl)Cl)C(C)(C)F.CC(C)(C)N |
| Isomeric SMILES | CC1=CN(C2=CC=CC(=C12)/C=C/C(=O)O)C(=O)C3=C(ON=C3C4=C(C=C(C=C4Cl)Cl)Cl)C(C)(C)F.CC(C)(C)N |
| PubChem CID | 139600317 |
| Molecular Weight | 608.92 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jan 31, 2024 | D414241 | |
| Certificate of Analysis | Jan 31, 2024 | D414241 | |
| Certificate of Analysis | Jan 31, 2024 | D414241 | |
| Certificate of Analysis | Jan 31, 2024 | D414241 | |
| Certificate of Analysis | Jan 31, 2024 | D414241 | |
| Certificate of Analysis | Jan 31, 2024 | D414241 | |
| Certificate of Analysis | Jan 31, 2024 | D414241 | |
| Certificate of Analysis | Jan 31, 2024 | D414241 |
| Solubility | Solubility (25°C) In vitro DMSO: 14 mg/mL (22.99 mM); Water: Insoluble; Ethanol: Insoluble; |
|---|---|
| Molecular Weight | 608.900 g/mol |
| XLogP3 | |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 607.121 Da |
| Monoisotopic Mass | 607.121 Da |
| Topological Polar Surface Area | 111.000 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 859.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 1 |
| Covalently-Bonded Unit Count | 2 |